Mei-Chen Hu Selected Research

Opioid Analgesics (Opioids)

12/2023	Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: a retrospective observational cohort study.
10/2023	Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment.
10/2023	Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances.
7/2023	Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence.
12/2022	Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment.
1/2022	Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials.
1/2019	Medical Use and Misuse of Prescription Opioids in the US Adult Population: 2016-2017.
6/2015	Web-based treatment for substance use disorders: differential effects by primary substance.
4/2014	Clinically relevant characteristics associated with early treatment drug use versus abstinence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei-Chen Hu Research Topics

Disease

23	Substance-Related Disorders (Drug Abuse) 04/2024 - 08/2008
9	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2019 - 07/2010
7	Opioid-Related Disorders (Opiate Addiction) 12/2023 - 01/2017
6	Wounds and Injuries (Trauma) 01/2017 - 04/2010
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017 - 01/2010
4	Tobacco Use Disorder (Nicotine Dependence) 10/2013 - 04/2007
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2018 - 07/2010
2	Marijuana Use 01/2019 - 01/2018
2	Mental Disorders (Mental Disorder) 01/2017 - 05/2011
2	Alcoholism (Alcohol Abuse) 04/2015 - 04/2014
1	Pain (Aches) 01/2019
1	Cognitive Dysfunction 03/2018
1	Cocaine-Related Disorders (Cocaine Addiction) 11/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2011

Drug/Important Bio-Agent (IBA)

12	N-nitrosoiminodiacetic acidIBA 12/2023 - 08/2008
9	Opioid Analgesics (Opioids)IBA 12/2023 - 04/2014
8	Methylphenidate (Ritalin)FDA LinkGeneric 11/2019 - 07/2010
6	Cocaine (Cocaine HCl)IBA 07/2023 - 04/2014
5	Methadone (Dolophine)FDA LinkGeneric 12/2023 - 01/2009
5	Nicotine FDA Link 01/2018 - 04/2007
4	trans-crotonin (CTN)IBA 04/2024 - 04/2014
4	Naltrexone (ReVia)FDA LinkGeneric 10/2023 - 01/2022
2	Buprenorphine (Subutex)FDA LinkGeneric 10/2023 - 10/2023
2	BenzodiazepinesIBA 01/2023 - 01/2019
2	TESIBA 01/2018 - 05/2015
2	Sertraline (Zoloft)FDA LinkGeneric 10/2016 - 04/2015
2	Carbon MonoxideIBA 06/2015 - 10/2013
2	SmokeIBA 08/2012 - 07/2010
1	Heroin (Diamorphine)IBA 01/2019
1	5,6-dihydroxy-2-dimethylaminotetralin (M 7)IBA 04/2015
1	Illicit Drugs (Recreational Drugs)IBA 05/2011

Therapy/Procedure

5	Tobacco Use Cessation Devices 12/2015 - 07/2010
1	Aftercare (After-Treatment) 07/2023
1	Injections 01/2022
1	Female Condoms (Female Condom) 08/2011
1	Self Medication 01/2010